Lilly expands specialty portfolio in India - The Times of India
India Business News: New Delhi: US firm Eli Lilly is deepening its specialty portfolio in India across cardio metabolic health, oncology, neurology and immunology, with th.
Ähnliche Seiten
Eli Lilly brings monthly Alzheimer's therapy donanemab to India at ₹91,688 per vial - The Economic Times